Eli Lilly's stock is a bit expensive, even with a bit of a decline this year.
Eli Lilly's soaring stock price has sparked 2026 split speculation. Here's what a potential LLY split could mean and what investors should consider now.
Sales of Mounjaro rose 99% in 2025. Zepbound's sales rose an even more impressive 175%. Eli Lilly is the clear leader in the ...
Zacks Investment Research on MSN
Here's why Eli Lilly (LLY) is a strong growth stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...
That's helped to supercharge Eli Lilly's (NYSE: LLY) growth and its stock price. However, you might be better off with this higher-yielding drug peer, even though it doesn't compete in the GLP-1 ...
With short-term returns turning negative, analysts are reassessing Lilly's high valuation, reminding the market that even ...
Zacks Investment Research on MSN
Eli Lilly (LLY) laps the stock market: Here's why
In the latest close session, Eli Lilly (LLY) was up +1.82% at $1,008.39. This move outpaced the S&P 500's daily gain of 0.83%. Elsewhere, the Dow gained 0.5%, while the tech-heavy Nasdaq added 1.38%.
Eli Lilly (NYSE: LLY) stock has pulled back 2.9% year-to-date to around $1,044, and institutional investors have been accumulating shares during the pullback, according to recent filings. The Earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results